ECIG Online Ltd d/b/a Vvapour – FDA Warning Letter, Dec 10, 2019
The FDA issued a Warning Letter to Jonathan Matthew Hewston of vvapour.co.uk after reviewing their website and determining that e-liquid products were advertised and sold to U.S. customers. These e-liquids are classified as tobacco products under the FD&C Act.
The FDA identified two primary violations: 1. **Sales to Minors:** The V-Juice Arctic Blast e-liquid was sold to a person younger than 18 years of age, violating 21 C.F.R. § 1140.14(b). This renders the product misbranded under section 903(a)(7)(B) of the FD&C Act. 2. **Failure to Include Required Nicotine Warning Statement:** Several e-liquid products (e.g., Menthol, Blues Bros High VG, Unicorn Juice, Hulk Blood) advertised on the website lacked the mandatory nicotine warning statement ("WARNING: This product contains nicotine. Nicotine is an addictive chemical.") as required by 21 C.F.R. § 1143.3(b). This omission causes these products to be misbranded under sections 903(a)(7)(B) and 903(a)(7)(A) of the FD&C Act, as the advertising is considered misleading due to the failure to reveal material facts.
The letter requires immediate correction of these violations and similar
ID · a653f546-4703-431b-b323-c63f3f336fef
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.